Clara reads the full Zepbound label against your chart, whether your indication is chronic weight management, obstructive sleep apnea, or both. Free to connect your records.
Get started How it worksClara auto-syncs your records from 150,000+ doctors' offices, hospitals, clinics, labs, and wearables. The AI reads BMI, comorbidity list, sleep study results or CPAP AHI, and thyroid/pancreatitis history against the Zepbound label before anything is prescribed. Free to start.
If you have OSA with obesity, Clara writes Zepbound on the OSA indication — which often improves coverage. If weight is the primary indication, it goes through on the obesity indication. A licensed physician signs the prescription before it reaches your pharmacy.
Zepbound titrates 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg in 2.5 mg increments at least four weeks apart4. Clara watches your weight trend, GI tolerability, AHI on CPAP downloads, and wearable sleep architecture between every step.
See whether your chart qualifies for Zepbound on obesity, OSA, or both before paying a cent.
Get started Free to connect your records. No credit card to start.Titration dose only, not therapeutic on its own. Clara uses these four weeks to watch how your gastrointestinal system handles the molecule before stepping up.
Each step at least four weeks apart. Clara watches weight trend, AHI changes if you're on CPAP, and side-effect frequency. Holds at the prior dose if your body isn't ready for the next step.
The maintenance doses studied in SURMOUNT-1 (weight management) and SURMOUNT-OSA (sleep apnea)4. Most patients stay below 15 mg if their trend hits target sooner.
If Zepbound isn't covered or isn't tolerated, Wegovy is the on-label semaglutide alternative for chronic weight management. Clara reads both labels against your chart and recommends whichever is more appropriate.
| Clara | Hims & Hers | Lemonaid Health | Your doctor | |
|---|---|---|---|---|
| OSA indication recognized and used | ✓ Reads CPAP, sleep study, wearable AHI | Weight-only intake | Weight program only | If your doctor knows about it |
| 24/7 AI clinical chat | ✓ Unlimited | Async Care Team messaging | Async provider messaging | ✗ |
| Full-chart eligibility check on every titration | ✓ | Single-condition intake | Per-category intake | Depends on visit length |
| Cost to start chatting | Free | $39 first-month membership | Brief eligibility assessment | $150+ copay per visit |
| Membership cost | From $25/mo cash-pay (HSA/FSA eligible); medication billed separately, may be covered by your insurance | $149/mo after first month; medication bundled, cash-pay | $49/mo; medication billed separately, cash-pay | Per-visit copay |
| Branded FDA-approved Zepbound | ✓ | Sells compounded tirzepatide alongside branded Zepbound, cash-pay | Sells compounded tirzepatide | ✓ |
| Prescription may be covered by your insurance | ✓ | ✗ | ✗ | ✓ |
| Cross-condition primary care | ✓ BP, lipids, thyroid, sleep, everything | Single-category | Partial, separate intakes | ✓ |
| Labs and biomarkers included in membership | Up to 108 on Concierge | Extra cost | Extra cost | Copay per test |
Most weight-loss telehealth sells compounded tirzepatide. Clara writes branded FDA-approved Zepbound.
Get started Your prescription may be covered by your insurance. HSA/FSA eligible.Zepbound was the first GLP-1 FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity4. That indication unlocks coverage paths that the obesity-only indication doesn't always reach. But the indication is only useful if a doctor is actually reading your sleep study, your CPAP downloads, and your wearable sleep data. That's the AI's job.
Clara ingests your sleep study report and downloads your CPAP AHI weekly if you connect ResMed myAir or Philips DreamMapper. The OSA indication for Zepbound requires moderate-to-severe disease, which is an AHI threshold the AI can verify before prescribing.
Insurers often cover Zepbound for OSA where they decline obesity-only coverage. Clara writes the script on the indication that's most clinically and financially appropriate for you, rather than defaulting to obesity for everyone.
SURMOUNT-OSA showed AHI reductions alongside weight loss4. Clara tracks both. If your AHI improves but weight plateaus, or vice versa, the AI surfaces the mismatch and queues a clinical review before the next step-up.
An AI that reads SURMOUNT, your sleep study, and your full chart in one pass.
Get started 150,000+ sources synced automatically. Cancel anytime.Start free. Connect your records. See what happens when an AI reads the right Zepbound label against your sleep data, weight trend, and labs.
Get started